Professor
UNC School of Medicine, North Carolina, United States
Terry Kenakin received his BS in Chemistry and PhD in Pharmacology from the University of Alberta, Canada. After a post-doctoral fellowship at University College London, U.K., he moved to the US to take a position as a Research Scientist at Burroughs-Wellcome in Research Triangle Park, NC. After 7 years, he moved to Glaxo (now GlaxoSmithKline) where he worked for 25 years in drug discovery. His research is on drug receptors, allosteric protein function and the application of pharmacology to drug discovery. He is the editor in Chief of the Journal of Receptors and Signal Transduction and is on numerous editorial boards. He is a Fellow of the British Pharmacological Society and has received a number of distinctions including the Goodman and Gilman award for receptor pharmacology from ASPET, the Gaddum Memorial award from the British Pharmacological Society and awards from the Dutch and Norwegian pharmacology societies. He currently is a professor of Pharmacology in the University of North Carolina School of Medicine in Chapel Hill, NC.
Disclosure information not submitted.
Saturday, February 5, 2022
8:30 AM – 4:30 PM
Sunday, February 6, 2022
8:30 AM – 4:30 PM